A Study of Virtual Reality and Linaclotide for IBS-C | MicrobiomeTrials← Back to trialsNCT05796388
A Study of Virtual Reality and Linaclotide for IBS-C
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-05-31Est. Completion: 2026-10
Enrollment target: 65 participants Locations- Mayo Clinic Florida, Jacksonville, Florida, United States
Other microbiome trials you might be interested in
Irritable Bowel SyndromeConstipation
The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated what side effects may occur, and …
Mesa, United StatesEst. completion Jul 2027
Irritable Bowel SyndromeDermatographismPost-prandial Diarrhea
Irritable bowel syndrome is a functional disorder of the gastrointestinal tract diagnosed with the Rome criteria. The Ro…
Cincinnati, United StatesCompleted Aug 31, 2026
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pai…
Erzurum, Turkey (Türkiye)Completed Jul 20, 2026